These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8551673

  • 1. [Echocardiographic examinations for mass-screening of cardiovascular abnormalities].
    Sato H, Ozaki H, Hori M.
    Rinsho Byori; 1995 Nov; 43(11):1108-12. PubMed ID: 8551673
    [Abstract] [Full Text] [Related]

  • 2. Echocardiographic and electrocardiographic findings in juvenile hypertension.
    Niederle P, Widimský J, Jandová R.
    Cor Vasa; 1981 Nov; 23(4):257-64. PubMed ID: 6457730
    [Abstract] [Full Text] [Related]

  • 3. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Nov; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 4. [Mitral valve prolapse: two-dimensional echocardiographic screening in apparently healthy students].
    Fujii K, Ishida Y, Tanouchi J, Ishihara K, Matsuyama T, Nishioka H, Uematsu M, Ozaki H, Tani A, Kitabatake A.
    J Cardiol Suppl; 1988 Nov; 18():9-17, discussion 18-9. PubMed ID: 3267187
    [Abstract] [Full Text] [Related]

  • 5. Specificity of electrocardiographic myocardial infarction screening criteria in patients with nonischemic cardiomyopathies.
    Shah BR, Lin C, Maynard C, Bart B, Selvester RH, Shaw LK, O'Connor C, Wagner GS.
    Am Heart J; 1998 Aug; 136(2):314-9. PubMed ID: 9704696
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S.
    J Am Coll Cardiol; 2008 Mar 11; 51(10):1033-9. PubMed ID: 18325444
    [Abstract] [Full Text] [Related]

  • 7. [Mass screening of cardiovascular disorders by two-dimensional echocardiography].
    Kuroda T, Shiina A, Tsuruda K, Fujita T, Yamasawa M, Mitsuhashi T, Suzuki O, Yaginuma T, Hosoda S.
    J Cardiol; 1989 Sep 11; 19(3):933-43. PubMed ID: 2534926
    [Abstract] [Full Text] [Related]

  • 8. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May 11; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of cardiomyopathy in apparently healthy cats.
    Paige CF, Abbott JA, Elvinger F, Pyle RL.
    J Am Vet Med Assoc; 2009 Jun 01; 234(11):1398-403. PubMed ID: 19480619
    [Abstract] [Full Text] [Related]

  • 13. Value of convex-type ST-segment elevation and abnormal Q waves for electrocardiographic-based identification of left ventricular remodeling in hypertrophic cardiomyopathy.
    Furuki M, Kawai H, Onishi T, Hirata K.
    Kobe J Med Sci; 2009 Jun 05; 55(1):E16-29. PubMed ID: 19628972
    [Abstract] [Full Text] [Related]

  • 14. Brain natriuretic peptide detects cardiac abnormalities in mass screening.
    Takase H, Toriyama T, Sugiura T, Takahashi A, Sugiyama M, Ohashi M, Ueda R, Dohi Y.
    Eur J Clin Invest; 2007 Apr 05; 37(4):257-62. PubMed ID: 17373960
    [Abstract] [Full Text] [Related]

  • 15. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G.
    G Ital Cardiol (Rome); 2008 Dec 05; 9(12):835-43. PubMed ID: 19119693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.